Ajai Chari, MD
Icahn School of Medicine at Mount Sinai
5
5
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Ravi Vij, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
PEGOURIE, MD
University Hospital, Grenoble
Shared therapeutic areas:
Michel ATTAL, MD, PhD
University Hospital, Toulouse
Shared therapeutic areas:
AUGEL MEUNIER, MD
CHU ST PRIEST EN JAREZ
Shared therapeutic areas:
MOREL, MD
Hôpital la Pitié Salpêtrière Paris
Shared therapeutic areas:
BENBRAHIM, MD
CH ORLEANS
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Gustavo Leone
Medical University of South Carolina, Hollings Cancer Center
Shared therapeutic areas:
WETTERWALD, MD
CH DUNKERQUE
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients
Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)
Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
All 5 trials loaded